These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 2455880)
41. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy. Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342 [TBL] [Abstract][Full Text] [Related]
42. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease]. Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299 [TBL] [Abstract][Full Text] [Related]
43. Bilateral theca lutein cysts: a rare cause of acute abdomen in pregnancy. Upadhyaya G; Goswami A; Babu S Emerg Med Australas; 2004; 16(5-6):476-7. PubMed ID: 15537414 [TBL] [Abstract][Full Text] [Related]
45. Disappearance of serum progesterone: after normal delivery and removal of hydatidiform mole. Dawood MY; Teoh ES Obstet Gynecol; 1975 Jan; 45(1):9-12. PubMed ID: 1110825 [TBL] [Abstract][Full Text] [Related]
46. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy. Ngan HY; Wong LC Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563 [TBL] [Abstract][Full Text] [Related]
47. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands. Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825 [TBL] [Abstract][Full Text] [Related]
49. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia. Rotmensch J; Rosenshein NB; Block BS Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190 [TBL] [Abstract][Full Text] [Related]
50. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study. Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909 [TBL] [Abstract][Full Text] [Related]
51. Enormously enlarged ovaries due to multiple theca-lutein cysts associated with chorioadenoma destruens. Csapó Z; Zámbó Z; Csömör S; Berbik I; Treit S Patol Pol; 1979; 30(2):203-9. PubMed ID: 225713 [No Abstract] [Full Text] [Related]
52. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department. Mundangepfupfu T; Waseem M J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605 [TBL] [Abstract][Full Text] [Related]
58. Predictors of low risk of persistent trophoblastic disease in molar pregnancies. Niemann I; Petersen LK; Hansen ES; Sunde L Obstet Gynecol; 2006 May; 107(5):1006-11. PubMed ID: 16648403 [TBL] [Abstract][Full Text] [Related]
59. Guidelines following hydatidiform mole: a reappraisal. Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032 [TBL] [Abstract][Full Text] [Related]